9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
8 hedge funds and large institutions have $193K invested in 9 Meters Biopharma in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
164% more capital invested
Capital invested by funds: $73K → $193K (+$120K)
14% more funds holding
Funds holding: 7 → 8 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$86K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$42.4K |
| 3 |
RPG
Risk Paradigm Group
Austin,
Texas
|
+$21.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.56K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $77K | +$86K | +550 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $38K | +$42.4K | +271 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $28K | +$1.56K | +10 | +5% |
|
|
RPG
4
Risk Paradigm Group
Austin,
Texas
| $18.9K | +$21.1K | +135 | New |
|
|
RJFSA
5
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $15K | – | – | – |
|
6
Northern Trust
Chicago,
Illinois
| $8K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $8K | +$1.56K | +10 | +22% |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$2K | -22 | Closed |
|
NMTR Hedge Fund Activity: Q3 2017 in Review
8 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2017, worth a combined $193K — up 164% from $73K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NMTR positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $86K. The largest seller was Deutsche Bank, exiting entirely with an estimated $2K sold.
- 8 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2017, up from 7 in Q2 2017.
- Funds reported $193K of 9 Meters Biopharma stock for Q3 2017, up 164% quarter-over-quarter.
- 3 funds opened new 9 Meters Biopharma positions in Q3 2017 and 1 closed out, a net change of +2 holders.
- The largest 9 Meters Biopharma buyer in Q3 2017 was Virtu Financial, an estimated $86K added.
- The largest 9 Meters Biopharma seller in Q3 2017 was Deutsche Bank, an estimated $2K sold.
Based on aggregated 13F filings for Q3 2017.